Publications by authors named "Vincent D de Jager"

Claim this Profile
L
Large language model-based approach for low-cost, rapid and accurate automated extraction of predictive biomarker testing results from Dutch pathology reports.
Vincent D de Jager, Michiel van der Ree, Betzabel Cajiao Garcia, Chantal Kuijpers, Anthonie J van der Wekken

Virchows Arch· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients.
Paul van der Leest, Pim Rozendal, Naomi Rifaela, Anthonie J van der Wekken, Hanneke Kievit, Vincent D de Jager

Commun Med (Lond)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop.
Vincent D de Jager, Patrizio Giacomini, Jennifer A Fairley, Rodrigo A Toledo, Simon J Patton

EBioMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of / Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report.
Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib.
Vincent D de Jager, Jos A Stigt, Maarten Niemantsverdriet, Arja Ter Elst, Anthonie J van der Wekken

NPJ Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.
Vincent D de Jager, Wim Timens, Arnaud Bayle, Johan Botling, Luka Brcic

Lancet Reg Health Eur· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer.
Vincent D de Jager, Wim Timens, Arnaud Bayle, Johan Botling, Luka Brcic

Lancet Reg Health Eur· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland.
Vincent D de Jager, Sebastiaan A H J de Visscher, Ed Schuuring, Jan J Doff, Léon C van Kempen

Genes Chromosomes Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high urea-to-creatinine ratio predicts long-term mortality independent of acute kidney injury among patients hospitalized with an infection.
Elisabeth C van der Slikke, Bastiaan S Star, Vincent D de Jager, Marije B M Leferink, Lotte M Klein

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Resuscitation Strategies to Prevent Organ Dysfunction in Sepsis.
Vera A Reitsema, Bastiaan S Star, Vincent D de Jager, Matijs van Meurs, Robert H Henning

Antioxid Redox Signal· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis